Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Reprogramming Müller glia via in vivo cell fusion regenerates murine photoreceptors
Daniela Sanges, … , Marta Nicolás, Maria Pia Cosma
Daniela Sanges, … , Marta Nicolás, Maria Pia Cosma
Published July 18, 2016
Citation Information: J Clin Invest. 2016;126(8):3104-3116. https://doi.org/10.1172/JCI85193.
View: Text | PDF
Research Article Article has an altmetric score of 16

Reprogramming Müller glia via in vivo cell fusion regenerates murine photoreceptors

  • Text
  • PDF
Abstract

Vision impairments and blindness caused by retinitis pigmentosa result from severe neurodegeneration that leads to a loss of photoreceptors, the specialized light-sensitive neurons that enable vision. Although the mammalian nervous system is unable to replace neurons lost due to degeneration, therapeutic approaches to reprogram resident glial cells to replace retinal neurons have been proposed. Here, we demonstrate that retinal Müller glia can be reprogrammed in vivo into retinal precursors that then differentiate into photoreceptors. We transplanted hematopoietic stem and progenitor cells (HSPCs) into retinas affected by photoreceptor degeneration and observed spontaneous cell fusion events between Müller glia and the transplanted cells. Activation of Wnt signaling in the transplanted HSPCs enhanced survival and proliferation of Müller-HSPC hybrids as well as their reprogramming into intermediate photoreceptor precursors. This suggests that Wnt signaling drives the reprogrammed cells toward a photoreceptor progenitor fate. Finally, Müller-HSPC hybrids differentiated into photoreceptors. Transplantation of HSPCs with activated Wnt functionally rescued the retinal degeneration phenotype in rd10 mice, a model for inherited retinitis pigmentosa. Together, these results suggest that photoreceptors can be generated by reprogramming Müller glia and that this approach may have potential as a strategy for reversing retinal degeneration.

Authors

Daniela Sanges, Giacoma Simonte, Umberto Di Vicino, Neus Romo, Isabel Pinilla, Marta Nicolás, Maria Pia Cosma

×

Figure 6

Functional rescue of the rd10 phenotype upon BIO-treated HSPC transplantation.

Options: View larger image (or click on image) Download as PowerPoint
Functional rescue of the rd10 phenotype upon BIO-treated HSPC transplant...
(A) Representative H&E staining of 2-month-old rd10 retinas transplanted with BIO-treated HSPCs in the right eyes or with PBS in the left eyes as control. Scale bar: 20 μm. n = 8. (B) Statistical analysis of the maximum number of nuclear rows detected in the ONL of 2-month-old mouse retinas harvested from either WT or rd10 animals transplanted at P18 with BIO-treated HSPCs or treated with vehicle alone (PBS) as control. Data are represented as mean ± SEM. n = 8. ***P < 0.0001, unpaired Student’s t test. (C) Statistical analysis of the number of ONL nuclei rows detected in the nasal, central, or temporal retinal areas of 2-month-old rd10 right retinas transplanted with BIO-treated HSPCs with respect to left control (PBS) eyes. ***P < 0.0001, unpaired Student’s t test. Nine serial sections for each mouse (n = 8) were analyzed. Counts of 8 retinas out of 21 showed increased nuclear rows and were plotted. (D) Representative ERG responses of 2-month-old rd10 mice transplanted in the right eyes with BIO-treated HSPCs (BIO-HSPCs) or with vehicle alone (PBS) in left eyes as control. Data are represented as mean ± SD (n = 8) of the A-wave and B-wave amplitudes (μV) of ERG responses from 8 out of 21 treated mice that showed increased ONL thickness upon BIO-treated HSPC transplantation. ***P < 0.0001, unpaired Student’s t test. (E) Western blotting of PDE6B protein levels in retinas harvested from either 2-month-old WT or rd10 mice treated with PBS or transplanted with BIO-treated HSPCs at P18. Three different BIO-HSPC transplanted retinas were analyzed (no. 1, no. 2, no. 3).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 6 X users
Referenced in 1 patents
On 1 Facebook pages
103 readers on Mendeley
See more details